Related Experiment Videos
[Effects of antiplatelet serum on the pulmonary intravascular macrophage]
1First Department of Medicine, Hokkaido University School of Medicine.
Abstract:
Antiplatelet serum (APS) has been used to investigate the role of platelets in lung injury. However, the effect of APS on pulmonary intravascular macrophages (PIMs) is unknown. Therefore we investigated the effects of APS on PIMs. A bolus injection of APS raised pulmonary arterial pressure with the production of thromboxane. Fluorescence- and electronmicroscopy revealed that PIMs engulfed APS-platelets complexes after the APS injection. Repeated injections of APS increased the ratio of PIMs which engulfed platelets and the number of platelets in a PIM, but attenuated phagocytosis of liposomes by PIMs to decrease liposome-induced pulmonary hypertension and production of thromboxane. From the above data it was concluded that APS injection causes PIMs to engulf APS-platelets complexes, and that APS injection attenuates the phagocytosis of liposomes by PIMs, and thereby diminishes liposome-induced pulmonary hypertension and production of thromboxane.
Insights
Antiplatelet serum (APS) causes pulmonary intravascular macrophages (PIMs) to engulf platelet complexes, reducing liposome-induced pulmonary hypertension and thromboxane production. This study reveals a novel interaction between APS, platelets, and PIMs in lung injury models.
Area of Science:
- Pulmonary vascular biology
- Immunology
- Platelet-macrophage interactions
Context:
- Platelets play a role in lung injury, but their interaction with pulmonary intravascular macrophages (PIMs) is not well understood.
- Antiplatelet serum (APS) is used to study platelet function in lung injury.
- The specific effects of APS on PIMs remain unknown.
Purpose:
- To investigate the effects of antiplatelet serum (APS) on pulmonary intravascular macrophages (PIMs).
- To determine how APS influences platelet uptake by PIMs.
- To assess the impact of APS-mediated changes in PIMs on liposome-induced pulmonary hypertension.
Summary:
- A bolus injection of APS increased pulmonary arterial pressure and thromboxane production.
- Fluorescence and electron microscopy showed PIMs engulfing APS-platelet complexes post-injection.
- Repeated APS injections increased PIMs engulfing platelets but attenuated PIMs' phagocytosis of liposomes, decreasing liposome-induced pulmonary hypertension and thromboxane.
Impact:
- APS injection leads to PIMs engulfing APS-platelet complexes.
- APS attenuates PIMs' phagocytosis of liposomes, diminishing liposome-induced pulmonary hypertension.
- This research elucidates a novel mechanism by which APS affects PIMs and modulates lung injury responses.